{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:43:39Z","timestamp":1785545019211,"version":"3.56.0"},"reference-count":16,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Electronic patient-reported outcomes (ePROs) have demonstrated greater sensitivity in detecting adverse events than clinician-reported outcomes. However, conventional care faces challenges related to recall bias, and evidence from real-world populations of older adults is limited. This study evaluates the feasibility of an ePRO system integrated with ecological momentary assessment and ecological momentary intervention (EMI) to facilitate a concordance model within the framework of digital transformation in health care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to evaluate the satisfaction, usability, and clinical impact of an ePRO system integrated with ecological momentary assessment and EMI in a real-world cohort of older patients with lung cancer and to investigate its ability to facilitate a patient-centered concordance model within the framework of digital transformation in health care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-center prospective cohort study, 35 patients with lung cancer used the Welby My Carte ONC app to record daily symptoms and visual data. Satisfaction and usability were evaluated using 10-point scales at the end of the first and third treatment cycles. The study focused on the clinical impact of EMI triggered by ePRO data, such as early detection of toxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The cohort included a high proportion of older patients (20\/35, 57%) aged 70 to 89 years. Satisfaction and usability scores significantly improved over time (satisfaction: 6.0 to 8.0,\n                      <jats:italic>P<\/jats:italic>\n                      &lt;.001; usability: 5.0 to 8.0,\n                      <jats:italic>P<\/jats:italic>\n                      &lt;.001). ePRO monitoring enabled the early detection of critical events, including immune-related uveitis (case 1), Stevens-Johnson syndrome (case 2), rare drug-induced purpura (case 3), and the monitoring of infusion-related reactions (case 4).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ePRO monitoring is feasible for older patients with lung cancer and enhances safety through timely EMI. It serves as a core component of a comprehensive patient support program and supports the transition to a more active concordance model, ultimately improving patient well-being.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/97890","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T18:05:06Z","timestamp":1780941906000},"page":"e97890-e97890","source":"Crossref","is-referenced-by-count":0,"title":["Real-World Impact of Electronic Patient-Reported Outcomes on Early Intervention Among Older Patients With Lung Cancer: Prospective Cohort Study"],"prefix":"10.2196","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5729-2687","authenticated-orcid":false,"given":"Yasuhiro","family":"Nakajima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9141-9582","authenticated-orcid":false,"given":"Tetsushi","family":"Maesako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5951-3982","authenticated-orcid":false,"given":"Takashi","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3317-749X","authenticated-orcid":false,"given":"Daisuke","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7421-8457","authenticated-orcid":false,"given":"Toshiyuki","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0160-9662","authenticated-orcid":false,"given":"Arihiko","family":"Kanehiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8007-1516","authenticated-orcid":false,"given":"Kozo","family":"Kuribayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4249-4021","authenticated-orcid":false,"given":"Takashi","family":"Kijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"issue":"23","key":"R1","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1093\/jnci\/djp386","article-title":"Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes","volume":"101","author":"Basch","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"R2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial","volume":"34","author":"Basch","journal-title":"J Clin Oncol"},{"issue":"Pt 1","key":"R3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1348\/135910709X466063","article-title":"Ecological momentary interventions: incorporating mobile technology into psychosocial and health behaviour treatments","volume":"15","author":"Heron","journal-title":"Br J Health Psychol"},{"issue":"1","key":"R4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2147\/PPA.S101175","article-title":"The impact of patient support programs on adherence, clinical, humanistic, and economic patient outcomes: a targeted systematic review","volume":"10","author":"Ganguli","journal-title":"Patient Prefer Adherence"},{"issue":"8","key":"R5","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1200\/JCO.2016.70.5046","article-title":"Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial","volume":"35","author":"Temel","journal-title":"J Clin Oncol"},{"issue":"921","key":"R6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/pmj.78.921.383","article-title":"Defining shared decision making and concordance: are they one and the same?","volume":"78","author":"Jordan","journal-title":"Postgrad Med J"},{"issue":"3","key":"R7","doi-asserted-by":"publisher","DOI":"10.1093\/jamiaopen\/ooae056","article-title":"Development of an electronic health record-integrated patient-reported outcome-based shared decision-making dashboard in oncology","volume":"7","author":"Mohindra","journal-title":"JAMIA Open"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.2196\/49476","article-title":"Usability of electronic patient-reported outcome measures for older patients with cancer: secondary analysis of data from an observational single center study","volume":"25","author":"Riedl","journal-title":"J Med Internet Res"},{"issue":"5","key":"R9","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s10637-024-01464-w","article-title":"Clinical characteristics, treatment, and outcomes of pembrolizumab-induced uveitis","volume":"42","author":"Wu","journal-title":"Invest New Drugs"},{"issue":"6","key":"R10","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyaf143","article-title":"Clinical characteristics of Stevens-Johnson syndrome\/toxic epidermal necrolysis-like reactions induced by immune checkpoint inhibitors","volume":"30","author":"Zheng","journal-title":"Oncologist"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1523541","article-title":"Rare skin adverse reactions induced by osimertinib: a case report and literature review","volume":"15","author":"Zhang","journal-title":"Front Oncol"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2023.02.008","article-title":"Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study","volume":"178","author":"Park","journal-title":"Lung Cancer"},{"issue":"2","key":"R13","doi-asserted-by":"publisher","DOI":"10.2196\/39019","article-title":"The use of gamification in the self-management of patients with chronic diseases: scoping review","volume":"11","author":"Huang","journal-title":"JMIR Serious Games"},{"issue":"1","key":"R14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12955-017-0823-5","article-title":"Proxy and patient reports of health-related quality of life in a national cancer survey","volume":"16","author":"Roydhouse","journal-title":"Health Qual Life Outcomes"},{"issue":"11","key":"R15","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.8775","article-title":"Beyond adoption: a new framework for theorizing and evaluating nonadoption, abandonment, and challenges to the scale-up, spread, and sustainability of health and care technologies","volume":"19","author":"Greenhalgh","journal-title":"J Med Internet Res"},{"key":"R16","unstructured":"Machine learning models predict adverse events and survival in patients receiving immunotherapy. ESMO Daily Reporter. 2025. URL: https:\/\/dailyreporter.esmo.org\/esmo-targeted-anticancer-therapies-congress-2025\/highlights-from-tat-2025\/machine-learning-models-predict-adverse-events-and-survival-in-patients-receiving-immunotherapy [Accessed 21-06-2026]"}],"container-title":["JMIR Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cancer.jmir.org\/2026\/1\/e97890","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:23:10Z","timestamp":1785536590000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancer.jmir.org\/2026\/1\/e97890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":16,"URL":"https:\/\/doi.org\/10.2196\/97890","relation":{},"ISSN":["2369-1999"],"issn-type":[{"value":"2369-1999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"article-number":"v12i23e97890"}}